CMS rolled out details of the survey it expects 340B hospitals to use to provide the agency with drug acquisition costs under the drug discount program, and the agency intends to collect information starting in late March on prices from the end of 2018 and the beginning of 2019. “The acquisition cost data hospitals submit in response to this survey will be used to help determine payment amounts for drugs acquired under the 340B program. We want to ensure that...